Glucose levels at the site of subcutaneous insulin administration and their relationship to plasma levels.
OBJECTIVE
To examine insulin's effect on the tissue glucose concentration at the site of subcutaneous insulin administration.


METHODS
A CMA-60 microdialysis (MD) catheter and a 24-gauge microperfusion (MP) catheter were inserted into the subcutaneous adipose tissue of fasting, healthy subjects (n = 5). Both catheters were perfused with regular human insulin (100 units/ml) over a 6-h period and used for glucose sampling and simultaneous administration of insulin at sequential rates of 0.33, 0.66, and 1.00 units/h (each rate was used for 2 h). Before and after the insulin delivery period, both catheters were perfused with an insulin-free solution (5% mannitol) for 2 h and used for glucose sampling only. Blood plasma glucose was clamped at euglycemic levels during insulin delivery.


RESULTS
Start of insulin delivery with MD and MP catheters resulted in a decline of the tissue glucose concentration and the tissue-to-plasma glucose ratio (TPR) for approximately 60 min (P < 0.05). However, during the rest of the 6-h period of variable insulin delivery, tissue glucose concentration paralleled the plasma glucose concentration, and the TPR for MD and MP catheters remained unchanged at 83.2 +/- 3.1 and 77.1 +/- 4.8%, respectively. After subsequent switch to insulin-free perfusate, tissue glucose concentration and TPR increased slowly and reattained preinsulin delivery levels by the end of the experiments.


CONCLUSIONS
The results show the attainment of a stable TPR value at the site of insulin administration, thus indicating that insulin delivery and glucose sensing may be performed simultaneously at the same adipose tissue site.
Lindpointner
Stefan
S
Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria.
Korsatko
Stefan
S
Köhler
Gerd
G
Köhler
Hans
H
Schaller
Roland
R
Schaupp
Lukas
L
Ellmerer
Martin
M
Pieber
Thomas R
TR
Regittnig
Werner
W
D000328:Adult; D001786:Blood Glucose / Q000187:drug effects*; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000494:pharmacology; D055104:Infusions, Subcutaneous; D007328:Insulin / Q000008:administration & dosage* / Q000494:pharmacology; D008297:Male; D008962:Models, Theoretical; D040521:Subcutaneous Tissue / Q000378:metabolism*
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D005947:Glucose